Elanco Animal Health Inc. ELAN Long-Term Debt
Long-Term Debt at other companies
Other financials
Where this comes from
Reported directly by Elanco Animal Health Inc. in its filing.
Tagged under the XBRL concept us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities.
The official record: Elanco Animal Health Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Elanco Animal Health Inc.'s long-term debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Elanco Animal Health Inc.'s long-term debt?
- Elanco Animal Health Inc. (ELAN) reported long-term debt of $3.99B in Q1 2026.
- How has Elanco Animal Health Inc.'s long-term debt changed year-over-year?
- Elanco Animal Health Inc.'s long-term debt decreased by 8.3% year-over-year, from $4.35B to $3.99B.
- What is the long-term trend for Elanco Animal Health Inc.'s long-term debt?
- Over 5 years (2020 to 2025), Elanco Animal Health Inc.'s long-term debt has grown at a -6.3% compound annual growth rate (CAGR), from $5.57B to $4.02B.
- What does long-term debt mean?
- Debt that is not due for at least one year.
- How do you interpret long-term debt?
- High levels indicate significant leverage, which can amplify returns but also increase financial risk during economic downturns.
- How does long-term debt compare across companies?
- Varies by capital structure; pharmaceutical companies often carry significant debt to fund R&D and M&A.